NMTC
What one share of NeuroOne Medical Technologies holds
Surgical and Medical Instruments and Apparatus
(i) diagnostic, ablation and deep brain stimulation technology for brain related conditions such as epilepsy and Parkinson’s disease;
NeuroOne Medical Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.11 |
|---|---|
| Profit | −$0.87 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.84 |
| Cash and investments | $0.24 |
| Book value | $0.43 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $0.00 | −$0.03 | — | −$0.02 | — | −$0.02 |
| 2016 | $0.00 | −$0.18 | — | −$0.07 | — | −$0.92 |
| 2017 | — | −$13.77 | — | −$5.74 | — | −$11.53 |
| 2019 | — | −$10.29 | $0.09 | −$8.28 | — | −$1.65 |
| 2020 | — | −$15.11 | $0.14 | −$3.93 | — | $1.68 |
| 2021 | $0.10 | −$5.58 | $0.04 | −$4.86 | — | $3.27 |
| 2022 | $0.06 | −$3.75 | $0.10 | −$2.92 | — | $3.55 |
| 2023 | $0.65 | −$3.93 | $0.13 | −$4.39 | — | $1.57 |
| 2024 | $0.77 | −$2.76 | $0.03 | −$2.50 | — | $0.16 |
| 2025 | $1.36 | −$0.54 | $0.01 | −$0.44 | — | $0.85 |